IL245296A0 - Herbal composition, process for its preparation and use - Google Patents

Herbal composition, process for its preparation and use

Info

Publication number
IL245296A0
IL245296A0 IL245296A IL24529616A IL245296A0 IL 245296 A0 IL245296 A0 IL 245296A0 IL 245296 A IL245296 A IL 245296A IL 24529616 A IL24529616 A IL 24529616A IL 245296 A0 IL245296 A0 IL 245296A0
Authority
IL
Israel
Prior art keywords
preparation
herbal composition
herbal
composition
Prior art date
Application number
IL245296A
Other languages
English (en)
Hebrew (he)
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Publication of IL245296A0 publication Critical patent/IL245296A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL245296A 2013-10-28 2016-04-24 Herbal composition, process for its preparation and use IL245296A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361896321P 2013-10-28 2013-10-28
PCT/IB2014/065649 WO2015063674A1 (en) 2013-10-28 2014-10-28 Herbal composition, process for its preparation and use thereof

Publications (1)

Publication Number Publication Date
IL245296A0 true IL245296A0 (en) 2016-06-30

Family

ID=53003431

Family Applications (1)

Application Number Title Priority Date Filing Date
IL245296A IL245296A0 (en) 2013-10-28 2016-04-24 Herbal composition, process for its preparation and use

Country Status (13)

Country Link
US (1) US20160296577A1 (enExample)
EP (1) EP3062803A4 (enExample)
JP (1) JP2016535746A (enExample)
KR (1) KR20160066558A (enExample)
CN (1) CN105682670A (enExample)
AU (1) AU2014343262A1 (enExample)
CA (1) CA2928542A1 (enExample)
CL (1) CL2016000998A1 (enExample)
IL (1) IL245296A0 (enExample)
MX (1) MX2016005576A (enExample)
PH (1) PH12016500775A1 (enExample)
RU (1) RU2016120665A (enExample)
WO (1) WO2015063674A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105054253A (zh) * 2015-07-27 2015-11-18 广西鹿寨方田贸易有限公司 罗汉果烘干方法
US10675319B2 (en) 2016-06-21 2020-06-09 Tci Co., Ltd. Method for regulating circadian clock, regulating diurnal preference, adjusting a biological clock, improving sleep quality and/or facilitating sleep by using momordica charantia extract
IT201700002235A1 (it) * 2017-06-07 2018-12-07 Arche Frama Srls Composizione per somministrazione orale utile nel trattamento del diabete e delle sindrome metaboliche in genere
RU2020100072A (ru) 2017-07-11 2021-08-11 Пфайзер Инк. Иммуногенные композиции, содержащие cea, muc1 и tert
CN110376294B (zh) * 2019-05-28 2021-07-23 神威药业集团有限公司 一种瓜蒌配方颗粒指纹图谱的构建方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183747B1 (en) * 1999-07-14 2001-02-06 Kaijun Ren Use of plant Momordica charactia extracts for treatment of acne acid
CA2825845C (en) * 2011-01-28 2019-08-27 Piramal Life Sciences Ltd. Process for preparation of a herbal extract
CN103284083B (zh) * 2012-02-24 2016-06-08 中科云健康科技(天津)有限公司 高维生素c含量的苦瓜干品及其制备方法

Also Published As

Publication number Publication date
EP3062803A4 (en) 2017-05-03
CN105682670A (zh) 2016-06-15
WO2015063674A1 (en) 2015-05-07
KR20160066558A (ko) 2016-06-10
CA2928542A1 (en) 2015-05-07
EP3062803A1 (en) 2016-09-07
RU2016120665A3 (enExample) 2018-06-09
AU2014343262A1 (en) 2016-06-02
US20160296577A1 (en) 2016-10-13
PH12016500775A1 (en) 2016-05-30
CL2016000998A1 (es) 2017-01-20
JP2016535746A (ja) 2016-11-17
RU2016120665A (ru) 2017-12-01
MX2016005576A (es) 2016-12-09

Similar Documents

Publication Publication Date Title
IL285390A (en) Arylquinazolines, their preparation and pharmaceutical preparations containing them
RS67779B1 (sr) Farmaceutska kompozicija, postupci za lečenje i njihova primena
GB201520943D0 (en) Novel linker and preparation method thereof
GB201321693D0 (en) Composition and uses thereof
ZA201509307B (en) Pharmaceutical composition, preparation and uses thereof
PL3027750T3 (pl) Kompozycja biokatalityczna
IL242437B (en) Compound 9, 5-dimethyl-9-hydroxy-decan-4-al, its use and its preparation process
PL2956491T3 (pl) Duroplasty, sposoby wytwarzania, zastosowania i kompozycje składników
SG11201507608PA (en) Toxoid, compositions and related methods
IL243699A0 (en) Benzoxaborole-type substances, a process for their preparation and preparations containing them
ZA201600015B (en) Anti-fibrogenic compounds, methods and uses thereof
EP3037099A4 (en) Pharmaceutical composition, preparation method therefor and use thereof
ZA201504748B (en) New antibody fragments, compositions and uses thereof
EP2950646A4 (en) AGROCHEMICAL COMPOSITION, PROCESS FOR PREPARATION AND USE THEREOF
EP3062803A4 (en) Herbal composition, process for its preparation and use thereof
EP2952519A4 (en) PROTOPANOXADIOL DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF
GB201301979D0 (en) New composition and use thereof
SG11201507578PA (en) Toxoid, compositions and related methods
EP2980096A4 (en) 2,3,5-trihydroxy-androst-6-one, as well as method of preparation and use thereof
EP2977051A4 (en) GINSENOSIDZUSAMMENSETZUNG
ZA201603682B (en) Taxanes compounds, preparation method therefor, and uses thereof
GB2550089B (en) Agrochemical composition, method for its preparation and the use thereof
GB2513859B (en) Agrochemical composition, method for its preparation and the use thereof
IL284405A (en) Pharmaceutical composition, preparation and uses thereof
HUE032883T2 (hu) Poliolok, elõállításuk és alkalmazásuk